Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1, Randomized, Placebo-Controlled, Double-Blind, Study of Safety,
Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Theravance Biopharma Theravance Biopharma R & D, Inc.